Electrical and structural remodeling: Role in the genesis and maintenance of atrial fibrillation

Progress in Cardiovascular Diseases

Volumn 48, Issue 3, 2005, Pages 153-168

  Schoonderwoerd, Bas A ^a   Van Gelder, Isabelle C ^b   Van Veldhuisen, Dirk J ^b   Van Den Berg, Maarten P ^b   Crijns, Harry J G M ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; TRANDOLAPRIL;

CARDIOVERSION; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DRUG EFFECT; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM CONDUCTION; HEART ATRIUM CONTRACTILITY; HEART ATRIUM CONTRACTION; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HEART ATRIUM PACING; HEART ELECTROPHYSIOLOGY; HEART RATE; HEART VENTRICLE PACING; HEMODYNAMICS; HUMAN; HYPERTENSION; MORPHOLOGY; NEUROENDOCRINE SYSTEM; NONHUMAN; PATHOPHYSIOLOGY; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT; RISK FACTOR; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME;

ACTION POTENTIALS; ANIMALS; ATRIAL FIBRILLATION; ATRIAL FUNCTION; HEART ATRIA; HUMANS; MICROSCOPY, ELECTRON; MYOCARDIAL CONTRACTION;

EID: 27644432680     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2005.06.014     Document Type: Review

References (167)

1. L.A. Van Leest, H.L. Koek, and M.L. Bots Heart and blood vessel diseases in the Netherlands, morbidity and mortality figures 2002 Netherlands Heart Foundation Press The Hague
2. F.D. Murgatroyd, and A.J. Camm Atrial arrhythmias Lancet 341 1993 1317 1322
3. J. Godtfredsen Atrial fibrillation: Etiology course and prognosis. A follow-up study of 1212 cases 1975 University of Copenhagen Copenhagen, Denmark
4. S.L. Kopecky, B.J. Gersh, and M.D. McGoon The natural history of lone atrial fibrillation. A population-based study over three decades N. Engl. J. Med. 317 1987 669 674
5. I.C. Van Gelder, H.J. Crijns, and W.H. Van Gilst Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter Am. J. Cardiol. 68 1991 41 46
6. H.J. Crijns, L.M. Van Wijk, and W.H. Van Gilst Acute conversion of atrial fibrillation to sinus rhythm: Clinical efficacy of flecainide acetate. Comparison of two regimens Eur. Heart J. 9 1988 634 638
7. M.C. Wijffels, C.J. Kirchhof, and R. Dorland Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats Circulation 92 1995 1954 1968
8. S.B. Olsson, S. Cotoi, and E. Varnauskas Monophasic action potential and sinus rhythm stability after conversion of atrial fibrillation Acta Med. Scand. 190 1971 381 387
9. P. Attuel, R. Childers, and B. Cauchemez Failure in the rate adaptation of the atrial refractory period: Its relationship to vulnerability Int. J. Cardiol. 2 1982 179 197
10. M. Boutjdir, J.Y. Le Heuzey, and T. Lavergne Inhomogeneity of cellular refractoriness in human atrium: Factor of arrhythmia? Pacing Clin. Electrophysiol. 9 1986 1095 1100
11. J.Y. Le Heuzey, M. Boutjdir, and S. Gagey Cellular aspects of atrial vulnerability P. Attuel P. Coumel M.J. Janse The atrium in health and disease 1989 Futura Publishing Mount Kisco, NY 81 94
12. C.A. Morillo, G.J. Klein, and D.L. Jones Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation Circulation 91 1995 1588 1595
13. A. Elvan, K. Wylie, and D.P. Zipes Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs. Electrophysiological remodeling Circulation 94 1996 2953 2960
14. R. Gaspo, R.F. Bosch, and M. Talajic Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model Circulation 96 1997 4027 4035
15. S. Fareh, C. Villemaire, and S. Nattel Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling Circulation 98 1998 2202 2209
16. E.G. Daoud, F. Bogun, and R. Goyal Effect of atrial fibrillation on atrial refractoriness in humans Circulation 94 1996 1600 1606
17. M.R. Franz, P.L. Karasik, and C. Li Electrical remodeling of the human atrium: Similar effects in patients with chronic atrial fibrillation and atrial flutter J. Am. Coll. Cardiol. 30 1997 1785 1792
18. B.J. Brundel, I.C. Van Gelder, and R.H. Henning Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation Circulation 103 2001 684 690
19. C. Pandozi, L. Bianconi, and M. Villani Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation Circulation 98 1998 2860 2865
20. W.C. Yu, S.H. Lee, and C.T. Tai Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man Cardiovasc. Res. 42 1999 470 476
21. L. Yue, J. Feng, and R. Gaspo Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation Circ. Res. 81 1997 512 525
22. L. Yue, P. Melnyk, and R. Gaspo Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation Circ. Res. 84 1999 776 784
23. D.R. Van Wagoner, A.L. Pond, and M. Lamorgese Atrial L-type Ca2+ currents and human atrial fibrillation (see comments) Circ. Res. 85 1999 428 436
24. R.F. Bosch, X. Zeng, and J.B. Grammer Ionic mechanisms of electrical remodeling in human atrial fibrillation Cardiovasc. Res. 44 1999 121 131
25. M. Skasa, E. Jungling, and E. Picht L-type calcium currents in atrial myocytes from patients with persistent and non-persistent atrial fibrillation Basic Res. Cardiol. 96 2001 151 159
26. A.J. Workman, K.A. Kane, and A.C. Rankin The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation Cardiovasc. Res. 52 2001 226 235
27. L.P. Lai, M.J. Su, and J.L. Lin Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: An insight into the mechanism of atrial electrical remodeling (In Process Citation) J. Am. Coll. Cardiol. 33 1999 1231 1237
28. B.J. Brundel, I.C. Van Gelder, and R.H. Henning Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation Cardiovasc. Res. 42 1999 443 454
29. I.C. Van Gelder, B.J. Brundel, and R.H. Henning Alterations in gene expression of proteins involved in the calcium handling in patients with atrial fibrillation J. Cardiovasc. Electrophysiol. 10 1999 552 560
30. U. Schotten, H. Haase, and D. Frechen The L-type Ca2+-channel subunits alpha1C and beta2 are not downregulated in atrial myocardium of patients with chronic atrial fibrillation J. Mol. Cell. Cardiol. 35 2003 437 443
31. + current densities and Kv15 expression are reduced in chronic human atrial fibrillation Circ. Res. 80 1997 772 781
32. + channels J. Am. Coll. Cardiol. 37 2001 926 932
33. + current in a chronic dog model of atrial fibrillation Circ. Res. 81 1997 1045 1052
34. H.M.W. van der Velden, L. van der Zee, and M.C. Wijffels Atrial fibrillation in the goat induces changes in monophasic action potential and mRNA expression of ion channels involved in repolarization J. Cardiovasc. Electrophysiol. 11 2000 1262 1269
35. P. Probst, N. Goldschlager, and A. Selzer Left atrial size and atrial fibrillation in mitral stenosis. Factors influencing their relationship Circulation 48 1973 1282 1287
36. W.L. Henry, J. Morganroth, and A.S. Pearlman Relation between echocardiographically determined left atrial size and atrial fibrillation Circulation 53 1976 273 279
37. A.J. Sanfilippo, V.M. Abascal, and M. Sheehan Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study (see comments) Circulation 82 1990 792 797
38. I.C. Van Gelder, H.J. Crijns, and W.H. Van Gilst Decrease of right and left atrial sizes after direct-current electrical cardioversion in chronic atrial fibrillation Am. J. Cardiol. 67 1991 93 95
39. A.T. Gosselink, H.J. Crijns, and H.P. Hamer Changes in left and right atrial size after cardioversion of atrial fibrillation: Role of mitral valve disease J. Am. Coll. Cardiol. 22 1993 1666 1672
40. W.J. Manning, D.I. Silverman, and S.E. Katz Impaired left, atrial mechanical function after cardioversion: Relation to the duration of atrial fibrillation J. Am. Coll. Cardiol. 23 1994 1535 1540
41. I.W. Black, D. Fatkin, and K.B. Sagar Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study Circulation 89 1994 2509 2513
42. E. Leistad, G. Christensen, and A. Ilebekk Atrial contractile performance after cessation of atrial fibrillation Am. J. Physiol. 264 1993 H104 H109
43. U. Schotten, M. Duytschaever, and J. Ausma Electrical and contractile remodeling during the first days of atrial fibrillation go hand in hand Circulation 107 2003 1433 1439
44. J.S. Graettinger, R.A. Carleton, and J.J. Muenster Circulatory consequences of changes in cardiac rhythm produced in patients by transthoracic direct-current shock J. Clin. Invest. 43 1964 2290 2302
45. J. Ausma, M. Wijffels, and F. Thone Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat Circulation 96 1997 3157 3163
46. G.W. Bailey, B.A. Braniff, and E.W. Hancock Relation of left atrial pathology to atrial fibrillation in mitral valvular disease Ann. Intern. Med. 69 1968 13 20
47. L. Mary-Rabine, A. Albert, and T.D. Pham The relationship of human atrial cellular electrophysiology to clinical function and ultrastructure Circ. Res. 52 1983 188 199
48. P.M. Kistler, P. Sanders, and S.P. Fynn Electrophysiologic and electroanatomic changes in the human atrium associated with age J. Am. Coll. Cardiol. 44 2004 109 116
49. A. Frustaci, C. Chimenti, and F. Bellocci Histological substrate of atrial biopsies in patients with lone atrial fibrillation Circulation 96 1997 1180 1184
50. B.J. Brundel, J. Ausma, and I.C. Van Gelder Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation Cardiovasc. Res. 54 2002 380 389
51. H.J. Jongsma, and R. Wilders Gap junctions in cardiovascular disease Circ. Res. 86 2000 1193 1197
52. H.M. van der Velden, M.J. van Kempen, and M.C. Wijffels Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat (see comments) J. Cardiovasc. Electrophysiol. 9 1998 596 607
53. H.M. van der Velden, J. Ausma, and M.B. Rook Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat Cardiovasc. Res. 46 2000 476 486
54. L. Polontchouk, J.A. Haefliger, and B. Ebelt Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria J. Am. Coll. Cardiol. 38 2001 883 891
55. U. Wetzel, A. Boldt, and J. Lauschke Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies Heart 91 2005 166 170
56. S. Kostin, G. Klein, and Z. Szalay Structural correlate of atrial fibrillation in human patients Cardiovasc. Res. 54 2002 361 379
57. T. Nao, T. Ohkusa, and Y. Hisamatsu Comparison of expression of connexin in right atrial myocardium in patients with chronic atrial fibrillation versus those in sinus rhythm Am. J. Cardiol. 91 2003 678 683
58. E.R. Levin, D.G. Gardner, and W.K. Samson Natriuretic peptides N. Engl. J. Med. 339 1998 321 328
59. D. Roy, F. Paillard, and D. Cassidy Aerial natriuretic factor during atrial fibrillation and supraventricular tachycardia J. Am. Coll. Cardiol. 9 1987 509 514
60. M.P. Van Den Berg, H.J. Crijns, and D.J. Van Veldhuisen Atrial natriuretic peptide in patients with heart failure and chronic atrial fibrillation: Role of duration of atrial fibrillation Am. Heart J. 135 1998 242 244
61. B.S. Edwards, R.S. Zimmerman, and T.R. Schwab Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor Circ. Res. 62 1988 191 195
62. K.P. Walsh, T.D. Williams, and C. Spiteri Role of atrial pressure and rate in release of atrial natriuretic peptide Am. J. Physiol. 254 1988 R607 R610
63. G. Christensen, and E. Leistad Atrial systolic pressure, as well as stretch, is a principal stimulus for release of ANF Am. J. Physiol. 272 1997 H820 H826
64. R.J. Schiebinger, and J. Linden Effect of atrial contraction frequency on atrial natriuretic peptide secretion Am. J. Physiol. 251 1986 H1095 H1099
65. G.E. Bilder, P.K. Siegl, and T.L. Schofield Chronotropic stimulation: A primary effector for release of atrial natriuretic factor Circ. Res. 64 1989 799 805
66. R.J. Schiebinger, Y. Li, and E.J. Cragoe Jr Calcium dependency of frequency-stimulated atrial natriuretic peptide secretion Hypertension 23 1994 710 716
67. S. Cardin, D. Li, and N. Thorin-Trescases Evolution of the atrial fibrillation substrate in experimental congestive heart failure: Angiotensin-dependent and -independent pathways Cardiovasc. Res. 60 2003 315 325
68. A. Goette, T. Staack, and C. Rocken Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation J. Am. Coll. Cardiol. 35 2000 1669 1677
69. A. Goette, M. Arndt, and C. Rocken Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans Circulation 101 2000 2678 2681
70. H. Nakashima, K. Kumagai, and H. Urata Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation Circulation 101 2000 2612 2617
71. K. Shinagawa, H. Mitamura, and S. Ogawa Effects of inhibiting Na(+)/H(+)-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling Cardiovasc. Res. 54 2002 438 446
72. K. Kumagai, H. Nakashima, and H. Urata Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation J. Am. Coll. Cardiol. 41 2003 2197 2204
73. S. Kaseda, and D.P. Zipes Contraction-excitation feedback in the atria: A cause of changes in refractoriness J. Am. Coll. Cardiol. 11 1988 1327 1336
74. T. Satoh, and D.P. Zipes Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation J. Cardiovasc. Electrophysiol. 7 1996 833 842
75. F. Solti, T. Vecsey, and V. Kekesi The effect of atrial dilatation on the genesis of atrial arrhythmias Cardiovasc. Res. 23 1989 882 886
76. F. Ravelli, and M. Allessie Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart Circulation 96 1997 1686 1695
77. S.C. Eijsbouts, M. Majidi, and M. van Zandvoort Effects of acute atrial dilation on heterogeneity in conduction in the isolated rabbit heart J. Cardiovasc. Electrophysiol. 14 2003 269 278
78. D. Li, S. Fareh, and T.K. Leung Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort Circulation 100 1999 87 95
79. J.M. Power, G.A. Beacom, and C.A. Alferness Susceptibility to atrial fibrillation: A study in an ovine model of pacing-induced early heart failure J. Cardiovasc. Electrophysiol. 9 1998 423 435
80. P.A. Boyden, L.P. Tilley, and A. Albala Mechanisms for atrial arrhythmias associated with cardiomyopathy: A study of feline hearts with primary myocardial disease Circulation 69 1984 1036 1047
81. P.A. Boyden, and B.F. Hoffman The effects on atrial electrophysiology and structure of surgically induced right atrial enlargement in dogs Circ. Res. 49 1981 1319 1331
82. S. Verheule, E. Wilson, and T. Everett Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation Circulation 107 2003 2615 2622
83. G. Fenelon, R.K. Shepard, and B.S. Stambler Focal origin of atrial tachycardia in dogs with rapid ventricular pacing-induced heart failure J. Cardiovasc. Electrophysiol. 14 2003 1093 1102
84. B.L. Le Grand, S. Hatem, and E. Deroubaix Depressed transient outward and calcium currents in dilated human atria Cardiovasc. Res. 28 1994 548 556
85. Y.J. Chen, C.T. Tai, and C.W. Chiou Inducibility of atrial fibrillation during atrioventricular pacing with varying intervals: Role of atrial electrophysiology and the autonomic nervous system J. Cardiovasc. Electrophysiol. 10 1999 1578 1585
86. H. Calkins, R. el Atassi, and A. Leon Effect of the atrioventricular relationship on atrial refractoriness in humans Pacing Clin. Electrophysiol. 15 1992 771 778
87. H. Calkins, R. el Atassi, and S. Kalbfleisch Effects of an acute increase in atrial pressure on atrial refractoriness in humans Pacing Clin. Electrophysiol. 15 1992 1674 1680
88. R.G. Tieleman, I.C. Van Gelder, and A.E. Tuinenburg Infra- and post-operative atrial refractory periods in relation to atrial arrhythmia history and the presence of mitral regurgitation Pacing Clin. Electrophysiol. (Part II)816 1999 (abstr.)
89. P.B. Sparks, H.G. Mond, and J.K. Vohra Electrical remodeling of the atria following loss of atrioventricular synchrony: A long-term study in humans Circulation 100 1999 1894 1900
90. P.B. Sparks, H.G. Mond, and J.K. Vohra Mechanical remodeling of the left atrium after loss of atrioventricular synchrony. A long-term study in humans Circulation 100 1999 1714 1721
91. J.B. Morton, P. Sanders, and J.K. Vohra Effect of chronic right atrial stretch on atrial electrical remodeling in patients with an atrial septal defect Circulation 107 2003 1775 1782
92. P. Sanders, J.B. Morton, and N.C. Davidson Electrical remodeling of the atria in congestive heart failure: Electrophysiological and electroanatomic mapping in humans Circulation 108 2003 1461 1468
93. D. Li, P. Melnyk, and J. Feng Effects of experimental heart failure on atrial cellular and ionic electrophysiology Circulation 101 2000 2631 2638
94. T.H. Cheng, F.Y. Lee, and J. Wei Comparison of calcium-current in isolated atrial myocytes from failing and nonfailing human hearts Mol. Cell. Biochem. 157 1996 157 162
95. J. Schreieck, Y. Wang, and M. Overbeck Altered transient outward current in human atrial myocytes of patients with reduced left ventricular function J. Cardiovasc. Electrophysiol. 11 2000 180 192
96. J. Mansourati, and B. Le Grand Transient outward current in young and adult diseased human atria Am. J. Physiol. 265 1993 H1466 H1470
97. + channel response to acetylcholine and to G protein-mediated activation in atrial myocytes isolated from failing human hearts Circulation 90 1994 2213 2224
98. Y. Shi, A. Ducharme, and D. Li Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation Cardiovasc. Res. 52 2001 217 225
99. M. Matsuda, and Y. Matsuda Mechanism of left atrial enlargement related to ventricular diastolic impairment in hypertension Clin. Cardiol. 19 1996 954 959
100. A.M. Pritchett, D.W. Mahoney, and S.J. Jacobsen Diastolic dysfunction and left atrial volume: A population-based study J. Am. Coll. Cardiol. 45 2005 87 92
101. K. Shinagawa, Y.F. Shi, and J.C. Tardif Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs Circulation 105 2002 2672 2678
102. C. Aime-Sempe, T. Folliguet, and C. Rucker-Martin Myocardial cell death in fibrillating and dilated human right atria J. Am. Coll. Cardiol. 34 1999 1577 1586
103. J.J. Fenoglio Jr, T.D. Pham, and A. Hordof Right atrial ultrastructure in congenital heart disease. II. Atrial septal defect: Effects of volume overload Am. J. Cardiol. 43 1979 820 827
104. T. Omland, A. Aakvaag, and V.V. Bonarjee Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93 1996 1963 1969
105. S.S. Gottlieb, M.L. Kukin, and D. Ahern Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure J. Am. Coll. Cardiol. 13 1989 1534 1539
106. J.C. Burnett Jr, P.C. Kao, and D.C. Hu Atrial natriuretic peptide elevation in congestive heart failure in the human Science 231 1986 1145 1147
107. H. Yasue, M. Yoshimura, and H. Sumida Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1994 195 203
108. G.W. Moe, C. Angus, and R.J. Howard Pathophysiological role of changing atrial size and pressure in modulation of atrial natriuretic factor during evolving experimental heart failure Cardiovasc. Res. 24 1990 570 577
109. M.T. Rademaker, C.J. Charles, and E.A. Espiner Natriuretic peptide responses to acute and chronic ventricular pacing in sheep Am. J. Physiol. 270 1996 H594 H602
110. A. Luchner, F. Muders, and O. Dietl Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction Cardiovasc. Res. 51 2001 601 607
111. H.P. Brunner-La Rocca, R.L. Woods, and D.M. Kaye Divergent effects of ANP and BNP in acute heart failure: Evidence for a putative BNP-selective receptor? J. Hypertens. 20 2002 1195 1201
112. D. Li, K. Shinagawa, and L. Pang Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure Circulation 104 2001 2608 2614
113. Y. Shi, D. Li, and J.C. Tardif Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure Cardiovasc. Res. 54 2002 456 461
114. O.D. Pedersen, H. Bagger, and L. Kober Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction Circulation 100 1999 376 380
115. E. Vermes, J.C. Tardif, and M.G. Bourassa Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: Insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials Circulation 107 2003 2926 2931
116. K. Wachtell, M. Lehto, and E. Gerdts Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study J. Am. Coll. Cardiol. 45 2005 712 719
117. T. Van Noord, H.J. Crijns, and M.P. Van Den Berg Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation BMC Cardiovasc. Disord. 5 2005 3
118. A.H. Madrid, M.G. Bueno, and J.M. Rebollo Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: A prospective and randomized study Circulation 106 2002 331 336
119. Effect of enalapril on survival inpatients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators (see comments) N. Engl. J. Med. 325 1991 293 302
120. H.C. Doval, D.R. Nul, and H.O. Grancelli Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) (see comments) Lancet 344 1994 493 498
121. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) (see comments) Lancet 353 1999 2001 2007
122. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group N. Engl. J. Med. 316 1987 1429 1435
123. W.B. Kannel, R.D. Abbott, and D.D. Savage Epidemiologic features of chronic atrial fibrillation: The Framingham study N. Engl. J. Med. 306 1982 1018 1022
124. S.M. Vaziri, M.G. Larson, and E.J. Benjamin Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study Circulation 89 1994 724 730
125. P.E. Carson, G.R. Johnson, and W.B. Dunkman The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group Circulation 87 1993 VI102 VI110
126. C. Opasich, L. Tavazzi, and D. Lucci Comparison of one-year outcome in women versus men with chronic congestive heart failure Am. J. Cardiol. 86 2000 353 357
127. P. Mahoney, S. Kimmel, and D. DeNofrio Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure Am. J. Cardiol. 83 1999 1544 1547
128. H.J. Crijns, G. Tjeerdsma, and P.J. de Kam Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure Eur. Heart J. 21 2000 1238 1245
129. K. Swedberg, L.G. Olsson, and A. Charlesworth Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: Results from COMET Eur. Heart J. 13 2005 1303 1308
130. H.R. Middlekauff, W.G. Stevenson, and L.W. Stevenson Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients Circulation 84 1991 40 48
131. D.L. Dries, D.V. Exner, and B.J. Gersh Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction J. Am. Coll. Cardiol. 32 1998 695 703
132. J. Mathew, S. Hunsberger, and J. Fleg Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure Chest 118 2000 914 922
133. K.L. Liem, K.I. Lie, and D. Durrer Clinical setting and prognostic significance of atrial fibrillation complicating acute myocardial infarction Eur. J. Cardiol. 4 1976 59 62
134. M.P. Van Den Berg, I.C. Van Gelder, and D.J. Van Veldhuisen Impact of atrial fibrillation on mortality in patients with chronic heart failure Eur. J. Heart Fail. 4 2002 571 575
135. M. Naito, D. David, and E.L. Michelson The hemodynamic consequences of cardiac arrhythmias: Evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model Am. Heart J. 106 1983 284 291
136. D.M. Clark, V.J. Plumb, and A.E. Epstein Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation J. Am. Coll. Cardiol. 30 1997 1039 1045
137. L. Resnekov Haemodynamic studies before and after electrical conversion of atrial fibrillation and flutter to sinus rhythm Br. Heart J. 29 1967 700 708
138. A. Gossage, and J. Hicks On auricular fibrillation Q. J. Med. 6 1913 435 440
139. E. Phillips, and S. Levine Auricular fibrillation without other evidence of heart disease: A cause of reversible heart failure Am. J. Med. 7 1949 478 489
140. I. Brill Congestive heart failure arising from uncontrolled auricular fibrillation in the otherwise normal heart: Follow-up notes on a previously reported case Am. J. Med. 2 1947 544 547
141. A. Natale, L. Zimerman, and G. Tomassoni Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response Am. J. Cardiol. 78 1996 1431 1433
142. I.C. Van Gelder, H.J. Crijns, and P.K. Blanksma Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease Am. J. Cardiol. 72 1993 560 566
143. D.L. Packer, G.H. Bardy, and S.J. Worley Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction Am. J. Cardiol. 57 1986 563 570
144. L.M. Rodriguez, J.L. Smeets, and B. Xie Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation Am. J. Cardiol. 72 1993 1137 1141
145. P.C. Gillette, D.G. Wampler, and A. Garson Jr Treatment of aerial automatic tachycardia by ablation procedures J. Am. Coll. Cardiol. 6 1985 405 409
146. G.H. Whipple, L.T. Sheffield, and E.G. Woodman Reversible congestive heart failure due to rapid stimulation of the normal heart Proc. N. Engl. Cardiovasc. Soc. 20 1962 39 40
147. F.G. Spinale, D.A. Hendrick, and F.A. Crawford Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine Am. J. Physiol. 259 1990 H218 H229
148. M. Tomita, F.G. Spinale, and F.A. Crawford Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function Circulation 83 1991 635 644
149. R. Tanaka, F.G. Spinale, and F.A. Crawford Effect of chronic supraventricular tachycardia on left ventricular function and structure in newborn pigs J. Am. Coll. Cardiol. 20 1992 1650 1660
150. R. Mukherjee, K.W. Hewett, and F.G. Spinale Myocyte electrophysiological properties following the development of supraventricular tachycardia-induced cardiomyopathy J. Mol. Cell. Cardiol. 27 1995 1333 1348
151. P.W. Armstrong, T.P. Stopps, and S.E. Ford Rapid ventricular pacing in the dog: Pathophysiologic studies of heart failure Circulation 74 1986 1075 1084
152. S. Kaab, H.B. Nuss, and N. Chiamvimonvat Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure Circ. Res. 78 1996 262 273
153. K. Kiuchi, R.P. Shannon, and K. Komamura Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure J. Clin. Invest. 91 1993 907 914
154. P.H. Pak, H.B. Nuss, and R.S. Tunin Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy J. Am. Coll. Cardiol. 30 1997 576 584
155. H.G. Li, D.L. Jones, and R. Yee Arrhythmogenic effects of catecholamines are decreased in heart failure induced by rapid pacing in dogs Am. J. Physiol. 265 1993 H1654 H1662
156. C.L. Perreault, R.P. Shannon, and K. Komamura Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure J. Clin. Invest. 89 1992 932 938
157. J.T. Colston, P. Kumar, and J.P. Chambers Altered sarcolemmal calcium channel density and Ca(2+)-pump ATPase activity in tachycardia heart failure Cell Calcium 16 1994 349 356
158. S.D. Prabhu, and G.L. Freeman Effect of tachycardia heart failure on the restitution of left ventricular function in closed-chest dogs Circulation 91 1995 176 185
159. W.X. Zhu, S.B. Johnson, and R. Brandt Impact of volume loading and load reduction on ventricular refractoriness and conduction properties in canine congestive heart failure J. Am. Coll. Cardiol. 30 1997 825 833
160. M.C. Haigney, S. Wei, and S. Kaab Loss of cardiac magnesium in experimental heart failure prolongs and destabilizes repolarization in dogs J. Am. Coll. Cardiol. 31 1998 701 706
161. J.S. Shinbane, M.A. Wood, and D.N. Jensen Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies J. Am. Coll. Cardiol. 29 1997 709 715
162. F.G. Spinale Pathology of tachycardia induced heart failure Monograph series. American Heart Association 1996 Futura Publishing Company Armonk, NY
163. F.G. Spinale, J.L. Zellner, and W.S. Johnson Cellular and extracellular remodeling with the development and recovery from tachycardia-induced cardiomyopathy: Changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans J. Mol. Cell. Cardiol. 28 1996 1591 1608
164. B.A. Schoonderwoerd, I.C. Van Gelder, and D.J. Van Veldhuisen Electrical remodeling and atrial dilation during atrial tachycardia are influenced by ventricular rate: Role of developing tachycardiomyopathy J. Cardiovasc. Electrophysiol. 12 2001 1404 1410
165. B.A. Schoonderwoerd, H.J. Crijns, and D.J. Van Veldhuisen Atrial natriuretic peptides during experimental atrial tachycardia: Role of developing tachycardiomyopathy J. Cardiovasc. Electrophysiol. 15 2004 927 932
166. B.A. Schoonderwoerd, J. Ausma, and H.J. Crijns Atrial ultrastructural changes during experimental atrial tachycardia depend on high ventricular rate J. Cardiovasc. Electrophysiol. 15 2004 1167 1174
167. T.J. Cha, J.R. Ehrlich, and L. Zhang Atrial ionic remodeling induced by atrial tachycardia in the presence of congestive heart failure Circulation 110 2004 1520 1526